Need immediate assistance? Call 1-518-730-0559 (Us-Canada Toll Free) or Contact Us

 

Insulin Pen Needles Market: Online Sales Emerging as a Lucrative Sales Distribution Channel

Press release Description

Albany, New York, January 18, 2018: A new comprehensive report based on insulin pen needles titled “Insulin Pen Needles Market – Global Industry Analysis, Size, Share, Growth, Trends and Forecast 2017 – 2026” has recently been added to the database of Market Research Reports Search Engine (MRRSE). According to the report, a value of US$ 3,800 Mn is projected to be generated by the global insulin pen needles market by the end of 2025.

According to the report, the global insulin pen needles market is likely to be driven by rising government support for curbing the menace of diabetes globally. The use of insulin pen needles in diabetes management and care is likely to provide an impetus to the growth of the market. In addition to diabetes, rising prevalence of HIV and hepatitis is also likely to provide an impetus to the growth of the market during the assessment period.

Although the insulin pen needles market is likely to grow at a steady pace during the assessment period, preference for non-invasive treatment options is a major challenge for manufacturers. Over the years, there has been a gradual shift towards non-invasive methods, and this has forced manufacturers to make gradual changes to their offerings.

Insulin pen needles are sold widely in many parts of the globe, and in many price sensitive countries, the standard insulin pen needles remain the highest selling. The standard insulin pens and needles segment is likely to account for a value of over a US$ 1 Bn by the end of 2026.

By distribution channel, online sales has emerged as a lucrative channel, with many vendors tying up with e-commerce companies to boost sales. The online sales segment is likely to grow at a robust pace during the assessment period. The hospital pharmacies distribution channel continues to be the largest distribution channel, and the status quo is unlikely to change during the assessment period. Sales of insulin pens and needles through hospital pharmacies have traditionally accounted for a leading revenue share of the total sales of a vendor.

The companies are profiled in terms of company overview, key financials, product overview and SWOT analysis. Some of the major companies profiled are Becton, Dickinson and Company, Terumo Corporation, Novo Nordisk A/S, Braun Melsungen AG, Owen Mumford Limited, Perrigo Co. Plc, HTL-STREFA S.A., UltiMed, Inc., VOGT MEDICAL VERTRIEB GMBH and MedExel Co., Ltd. Overall, the report is a comprehensive source of information and analysis on the insulin pen and needles market.

Browse Full Global Insulin Pen Needles Market Report with TOC : https://www.mrrse.com/global-insulin-pen-needles-market

Market Research Reports Search Engine (MRRSE) is an industry-leading database of market intelligence reports. MRRSE is driven by a stellar team of research experts and advisors trained to offer objective advice. Our sophisticated search algorithm returns results based on the report title, geographical region, publisher, or other keywords. 

MRRSE partners exclusively with leading global publishers to provide clients single-point access to top-of-the-line market research. MRRSE’s repository is updated every day to keep its clients ahead of the next new trend in market research, be it competitive intelligence, product or service trends or strategic consulting.

Contact

State Tower
90, State Street
Suite 700
Albany, NY – 12207
United States

Telephone: +1-518-730-0559
Email: sales@mrrse.com